A Real-world Study to Explore Recurrence/Metastases of the NSCLC Patients and the Impact Factors of Patient Survivals

• Conditions: Non-small Cell Lung Cancer

• Registration Number: NCT03710616
• Lead Sponsor: The First Affiliated Hospital of Guangzhou Medical University

Brief Summary

The real-world study was designed to explore recurrence/metastases of the patients with non-small cell lung cancer as measured by patient survivals and the impact factors of patient survivals.

Detailed Description

The trial was designed as a real-world observational study to recruit those patients with pathologically diagnosed early-phase non-small cell lung cancer (NSCLC) who were enrolled in the clinical form 2009 to 2017 and explore recurrence/metastases of the NSCLC patients as measured by patient survivals and the impact factors of patient survivals. The study data on patient demographic characteristics, tumor biological characteristics, and clinicla treatments were collected via a retrospectively review method for evaluation of patient survivals and the relevance of clinical characteristics of the patients and patient survivals.

Study Timeline

• Study Start: 2018-03-24
• Study First Submitted: 2018-07-10
• Study First Submitted QC: 2018-10-15
• Study First Posted: 2018-10-18
• Status Verified: 2019-07
• Last Update Submitted: 2019-07-31
• Last Update Posted: 2019-08-01
• Primary Completion: 2022-12-30
• Study Completion: 2023-01-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 700

Inclusion Criteria

The patients who meet all the following inclusion criteria will be included in the study:

• The patients who were operated with radical operations of the lung cancer;
• The patients with clinical I-IIIA staging tumors;
• The pathologically diagnosed NSCLC patients;

Exclusion Criteria

• Not be specified;

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Disease-free survival rates within the configured observation periods	2009-2017	Disease-free survival rates within 3-month, 6-month, 1-year, 2-year, and 3-year observation periods;

Secondary Outcome Measures

Name	Time	Method
Disease-free survival rates at the configured locations and observation periods	2009-2017	Disease-free survival rates at the metastasized lymph nodes, bone, and brain within 3-month, 6-month, 1-year, 2-year, and 3-year observation periods;

Trial Locations

Locations (1)

Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University; 🇨🇳 Guangzhou, Guangzhou, China